Famed Cannabis Researcher Paul G. Mahlberg Joins S
Post# of 82
Posted On: 04/28/2015 8:28:15 AM
Famed Cannabis Researcher Paul G. Mahlberg Joins Stevia Corp.'s Advisory Panel
INDIANAPOLIS, IN – (MARKETWIRE – April 28, 2015) – Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company"
, an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds is pleased to announce the addition of Dr. Paul Mahlberg to Stevia Corp.’s newly formed Advisory Panel.
Dr. Mahlberg obtained one of only two Drug Enforcement Administration (DEA) Schedule 1 research licenses to pursue studies on Cannabis in the United States spanning a period of 33 years from 1970-2003. During that time he accumulated one of the most extensive seed banks in the world with over 200 strains (varieties) of Cannabis from worldwide sources, which were cultivated in secure greenhouses. The studies are available in over 30 scientific publications on Cannabis.
Dr. Mahlberg is a Professor Emeritus of Indiana University and was an active professor in the Botany department of the University until 1994 after which he continued his research on Cannabis with visiting faculty and maintained his laboratory until 2003. Dr. Mahlberg received his Ph.D. in Botany from the University of California, Berkley and his M.S. and B.S. degrees in Botany from the University of Wisconsin, Madison.
Insert-tag-herewww.marketwired.com/press-release/stevia-corp-names-famed-cannabis-researcher-former-indiana-university-professor-paul-otcqb-stev-2013917.htm
INDIANAPOLIS, IN – (MARKETWIRE – April 28, 2015) – Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company"
, an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds is pleased to announce the addition of Dr. Paul Mahlberg to Stevia Corp.’s newly formed Advisory Panel. Dr. Mahlberg obtained one of only two Drug Enforcement Administration (DEA) Schedule 1 research licenses to pursue studies on Cannabis in the United States spanning a period of 33 years from 1970-2003. During that time he accumulated one of the most extensive seed banks in the world with over 200 strains (varieties) of Cannabis from worldwide sources, which were cultivated in secure greenhouses. The studies are available in over 30 scientific publications on Cannabis.
Dr. Mahlberg is a Professor Emeritus of Indiana University and was an active professor in the Botany department of the University until 1994 after which he continued his research on Cannabis with visiting faculty and maintained his laboratory until 2003. Dr. Mahlberg received his Ph.D. in Botany from the University of California, Berkley and his M.S. and B.S. degrees in Botany from the University of Wisconsin, Madison.
Insert-tag-herewww.marketwired.com/press-release/stevia-corp-names-famed-cannabis-researcher-former-indiana-university-professor-paul-otcqb-stev-2013917.htm
(0)
(0)Stevia Corp. (STEV) Stock Research Links
Scroll down for more posts ▼